Literature DB >> 14638823

Enhanced phagocytosis of Candida species mediated by opsonization with a recombinant human antibody single-chain variable fragment.

Melanie Wellington1, Joseph M Bliss, Constantine G Haidaris.   

Abstract

Specific antibody opsonization significantly enhances the level of phagocytosis of Candida in the absence of complement. Furthermore, we have described a system using a recombinant human antibody single-chain variable fragment that allows a comparative study of phagocytosis of multiple Candida species opsonized via a common antigen.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14638823      PMCID： PMC308946          DOI： 10.1128/IAI.71.12.7228-7231.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  27 in total

1.  High level production of soluble single chain antibodies in small-scale Escherichia coli cultures.

Authors:  S M Kipriyanov; G Moldenhauer; M Little
Journal:  J Immunol Methods       Date:  1997-01-15       Impact factor: 2.303

Review 2.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

3.  Differentiation of Candida albicans and Candida dubliniensis by using recombinant human antibody single-chain variable fragments specific for hyphae.

Authors:  Joseph M Bliss; Mark A Sullivan; Jane Malone; Constantine G Haidaris
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

4.  Interaction of Candida krusei with human neutrophils in vitro.

Authors:  M D Richardson; F Donaldson
Journal:  J Med Microbiol       Date:  1994-12       Impact factor: 2.472

5.  Soluble mannan and beta-glucan inhibit the uptake of Malassezia furfur by human monocytic cell line, THP-1.

Authors:  T Suzuki; N Ohno; Y Ohshima; T Yadomae
Journal:  FEMS Immunol Med Microbiol       Date:  1998-07

6.  Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Authors:  Carla Bromuro; Antonella Torosantucci; Paola Chiani; Stefania Conti; Luciano Polonelli; Antonio Cassone
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).

Authors:  S Tsuchiya; M Yamabe; Y Yamaguchi; Y Kobayashi; T Konno; K Tada
Journal:  Int J Cancer       Date:  1980-08       Impact factor: 7.396

8.  Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages.

Authors:  L Maródi; H M Korchak; R B Johnston
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

9.  Normal host defense during systemic candidiasis in mannose receptor-deficient mice.

Authors:  Sena J Lee; Nai-Ying Zheng; Monica Clavijo; Michel C Nussenzweig
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Antibody response that protects against disseminated candidiasis.

Authors:  Y Han; J E Cutler
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441
View more
  11 in total

1.  Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice.

Authors:  Mason X Zhang; M Charlotte Bohlman; Carol Itatani; Dennis R Burton; Paul W H I Parren; Stephen C St Jeor; Thomas R Kozel
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32).

Authors:  W W Shanaka I Rodrigo; Xia Jin; Shanley D Blackley; Robert C Rose; Jacob J Schlesinger
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Inhibition of Candida albicans adhesion by recombinant human antibody single-chain variable fragment specific for Als3p.

Authors:  Sonia S Laforce-Nesbitt; Mark A Sullivan; Lois L Hoyer; Joseph M Bliss
Journal:  FEMS Immunol Med Microbiol       Date:  2008-07-24

Review 4.  Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis.

Authors:  Cristina Cunha Villar; Anna Dongari-Bagtzoglou
Journal:  Expert Rev Mol Med       Date:  2008-10-13       Impact factor: 5.600

5.  Oxidative burst and phagocytosis of neonatal neutrophils confronting Candida albicans and Candida parapsilosis.

Authors:  Kisha G Destin; Jennifer R Linden; Sonia S Laforce-Nesbitt; Joseph M Bliss
Journal:  Early Hum Dev       Date:  2009-05-28       Impact factor: 2.079

6.  Deletion of Candida albicans SPT6 is not lethal but results in defective hyphal growth.

Authors:  Nada Al-Rawi; Sonia S Laforce-Nesbitt; Joseph M Bliss
Journal:  Fungal Genet Biol       Date:  2010-01-12       Impact factor: 3.495

7.  High efficiency opsonin-independent phagocytosis of Candida parapsilosis by human neutrophils.

Authors:  Jennifer R Linden; Matthew A Maccani; Sonia S Laforce-Nesbitt; Joseph M Bliss
Journal:  Med Mycol       Date:  2010-03       Impact factor: 4.076

8.  A novel real time imaging platform to quantify macrophage phagocytosis.

Authors:  Theodore S Kapellos; Lewis Taylor; Heyne Lee; Sally A Cowley; William S James; Asif J Iqbal; David R Greaves
Journal:  Biochem Pharmacol       Date:  2016-07-27       Impact factor: 5.858

9.  Inflammasome-mediated GSDMD activation facilitates escape of Candida albicans from macrophages.

Authors:  Xionghui Ding; Hiroto Kambara; Rongxia Guo; Apurva Kanneganti; Maikel Acosta-Zaldívar; Jiajia Li; Fei Liu; Ting Bei; Wanjun Qi; Xuemei Xie; Wenli Han; Ningning Liu; Cunling Zhang; Xiaoyu Zhang; Hongbo Yu; Li Zhao; Fengxia Ma; Julia R Köhler; Hongbo R Luo
Journal:  Nat Commun       Date:  2021-11-18       Impact factor: 14.919

10.  Combination Immunotherapy with Passive Antibody and Sulfasalazine Accelerates Fungal Clearance and Promotes the Resolution of Pneumocystis-Associated Immunopathogenesis.

Authors:  Zachary Hoy; Terry W Wright; Michael Elliott; Jane Malone; Samir Bhagwat; Jing Wang; Francis Gigliotti
Journal:  Infect Immun       Date:  2020-01-22       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.